420 related articles for article (PubMed ID: 17360156)
21. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
[TBL] [Abstract][Full Text] [Related]
22. Current concepts in the pathogenesis of primary biliary cirrhosis.
Charatcharoenwitthaya P; Lindor KD
Ann Hepatol; 2005; 4(3):161-75. PubMed ID: 16177655
[TBL] [Abstract][Full Text] [Related]
23. Concept on the pathogenesis and treatment of primary biliary cirrhosis.
Reshetnyak VI
World J Gastroenterol; 2006 Dec; 12(45):7250-62. PubMed ID: 17143938
[TBL] [Abstract][Full Text] [Related]
24. Xenobiotics and loss of tolerance in primary biliary cholangitis.
Wang J; Yang G; Dubrovsky AM; Choi J; Leung PS
World J Gastroenterol; 2016 Jan; 22(1):338-48. PubMed ID: 26755880
[TBL] [Abstract][Full Text] [Related]
25. Etiopathogenesis of primary biliary cirrhosis.
Lleo A; Invernizzi P; Mackay IR; Prince H; Zhong RQ; Gershwin ME
World J Gastroenterol; 2008 Jun; 14(21):3328-37. PubMed ID: 18528930
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic.
Migliaccio C; Van de Water J; Ansari AA; Kaplan MM; Coppel RL; Lam KS; Thompson RK; Stevenson F; Gershwin ME
Hepatology; 2001 Apr; 33(4):792-801. PubMed ID: 11283841
[TBL] [Abstract][Full Text] [Related]
27. The peculiar autoimmunity of primary biliary cirrhosis.
Mackay IR; Whittingham S; Fida S; Myers M; Ikuno N; Gershwin ME; Rowley MJ
Immunol Rev; 2000 Apr; 174():226-37. PubMed ID: 10807519
[TBL] [Abstract][Full Text] [Related]
28. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity.
Naiyanetr P; Butler JD; Meng L; Pfeiff J; Kenny TP; Guggenheim KG; Reiger R; Lam K; Kurth MJ; Ansari AA; Coppel RL; López-Hoyos M; Gershwin ME; Leung PS
J Autoimmun; 2011 Nov; 37(3):209-16. PubMed ID: 21763105
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes.
Leung PS; Cha S; Joplin RE; Galperin C; Van de Water J; Ansari AA; Coppel RL; Schatz PJ; Cwirla S; Fabris LE; Neuberger JM; Gershwin ME
J Autoimmun; 1996 Dec; 9(6):785-93. PubMed ID: 9115581
[TBL] [Abstract][Full Text] [Related]
30. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis?
Leung PS; Lam K; Kurth MJ; Coppel RL; Gershwin ME
Trends Mol Med; 2012 Oct; 18(10):577-82. PubMed ID: 22920894
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial antigens, molecular mimicry and autoimmune disease.
Baum H
Biochim Biophys Acta; 1995 May; 1271(1):111-21. PubMed ID: 7541246
[TBL] [Abstract][Full Text] [Related]
32. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
[TBL] [Abstract][Full Text] [Related]
33. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.
Surh CD; Ahmed-Ansari A; Gershwin ME
J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis.
Migliaccio C; Nishio A; Van de Water J; Ansari AA; Leung PS; Nakanuma Y; Coppel RL; Gershwin ME
J Immunol; 1998 Nov; 161(10):5157-63. PubMed ID: 9820485
[TBL] [Abstract][Full Text] [Related]
35. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic.
Sasaki M; Ansari A; Pumford N; van de Water J; Leung PS; Humphries KM; Szweda LI; Nakanuma Y; Roche TE; Coppel RL; Bach JF; Gershwin ME
J Autoimmun; 2000 Aug; 15(1):51-60. PubMed ID: 10936028
[TBL] [Abstract][Full Text] [Related]
36. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
[TBL] [Abstract][Full Text] [Related]
37. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry.
Teoh KL; Mackay IR; Rowley MJ; Fussey SP
Hepatology; 1994 Apr; 19(4):1029-33. PubMed ID: 8138243
[TBL] [Abstract][Full Text] [Related]
38. Immunopathogenesis of primary biliary cirrhosis.
Nishio A; Keeffe EB; Gershwin ME
Semin Liver Dis; 2002 Aug; 22(3):291-302. PubMed ID: 12360422
[TBL] [Abstract][Full Text] [Related]
39. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.
Amano K; Leung PS; Xu Q; Marik J; Quan C; Kurth MJ; Nantz MH; Ansari AA; Lam KS; Zeniya M; Coppel RL; Gershwin ME
J Immunol; 2004 May; 172(10):6444-52. PubMed ID: 15128836
[TBL] [Abstract][Full Text] [Related]
40. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
